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ABSTRACT
Clinician Detection of Depression in Late Life
Jeffrey J. Gregg
Depression in late life is associated with decreased cognitive functioning, increased social
and functional impairment, and overall increased mortality. Because of these negative health
implications, the accurate assessment of late-life depression is a critical public health issue. Prior
research has consistently demonstrated that older adults typically seek and receive mental health
services from general medical settings instead of mental health specialty clinics. Unfortunately,
many studies have shown that primary care physicians often fail to recognize depression. In
addition, older adults are less likely than younger adults to endorse symptoms of sadness or
dysphoria. Those with cognitive impairment are also less likely to exhibit depressed affect and it
is often difficult to distinguish between depression and cognitive impairment. The present study
examined the possible moderating effect of level of cognitive functioning and the endorsement
of depressed affect on the relation between overall level of depressive symptoms and the
clinician diagnosis of depression in a population-based sample of 344 adults (age ≥ 50). Results
indicated that the endorsement of one item that assessed depressed affect on the Center for
Epidemiologic Studies- Depression scale (i.e., “I felt depressed”) moderated the relation between
overall level of depressive symptoms and the clinician diagnosis of late-life depression.
However, a separate item that assessed depressed affect on the same scale (i.e., “I felt sad”) did
not moderate this relation. In addition, level of cognitive functioning did not moderate the
relation between overall level of depressive symptoms and the clinician diagnosis of depression
in late-life. Implications, limitations, and future directions are discussed.
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Diagnosis of Depression in Late Life 1
Clinician Detection of Depression in Late Life
Major depression has been shown to be less prevalent in older adults than in younger
adults (Hasin, Goodwin, Stinson, & Grant, 2005). However, 15% of community dwelling older
adults are estimated to have clinically significant depressive symptoms. Though major
depression appears to be less common in older adults, it is associated with decreased cognitive
functioning, increased social and functional impairment, and overall increased mortality (Blazer,
2003). In addition, depression is one of the most prominent risk factors for suicide in late life
and 85% of older adults who commit suicide are depressed (Conwell & Brent, 1996). Because
of the negative health implications associated with depression in late life, the accurate
assessment of depression in older adults is a critical public health issue.
Prevalence rates for major depression in community dwelling adults aged 65 and older
range between 1% and 5% (Hasin et al., 2005). Depression rates for special populations of older
adults tend to be higher, including medical inpatients (10%-15%) and residents of long-term care
facilities (14%-42%; Blazer, 2003; Djernes, 2006). Though prevalence rates of major depression
represent a significant decline from middle age to late life, endorsement of depressive symptoms
actually increases with age (Newmann, 1989). These statistics suggest that the detection of latelife depression is a complex issue. Furthermore, many studies have shown that major depression
is underdiagnosed in primary care, where most older adults seek treatment (e.g., Katon &
Schulberg, 1992). The current study seeks to characterize factors that may interfere with the
detection of depression in late life, particularly, the differential presentation of depression in late
life and the presence of cognitive impairment in older adults.
Physician Detection of Depression
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Prior research has consistently demonstrated that older adults typically seek and receive
mental health services from general medical settings (i.e. primary care physicians) instead of
mental health specialty clinics (Harmon, Veazie, & Lyness, 2006). One recent study found that
older adults were one third as likely as younger adults to seek specialty mental health services
(Bogner, de Vries, Maulik, & Unützer, 2009). Licht-Strunk et al. (2005) examined the
prevalence of depression in 5,686 Dutch older adults who consulted their primary care physician.
They found that 13.7% of the participants screened positive for major depression, and 10.2%
screened positive for minor depression. Overall depression increased with age, although
incidence of minor depression also increased with age. The study did not report how many
individuals were diagnosed with depression by their primary care physician.
Unfortunately, many studies have demonstrated that primary care physicians often fail to
recognize depression (Jencks, 1985; Katon & Schulberg, 1992). Mitchell, Vaze, and Rao (2009)
conducted a meta-analysis examining the clinical diagnosis of depression in primary care settings
utilizing 50,371 patients across 41 studies. They found that general practitioners correctly
identified depression in only 47.3% of cases. Using the 19 studies that employed both rule-in
and rule-out categories, they found that physicians had a weighted sensitivity of only 50.1%, but
a specificity of 81.3%. Additionally, Simon and Von Korff (1995) found that only 29% of
patients with subthreshold depression were accurately assessed by their primary care physician.
Symptom severity will be discussed in further detail and is an important theme in this proposal.
One possible explanation for low rates of detection of depression in primary care is that
many depressed patients who present to their physicians have a high level of medical
comorbidity, with their chief complaints being somatic symptoms. The evaluation of these
somatic symptoms takes time and resources and may complicate and delay a diagnosis of
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depression (Klinkman, 2003). Adults with certain age-related medical conditions, such as
Parkinson’s disease and Alzheimer’s disease, are also likely to experience milder forms of
depression, and without symptoms of dysphoria (Ehrt, Brønnick, Leentjens, Larsen, & Aarsland,
2006; Olin et al., 2002). In fact, Olin et al. (2002) have developed and proposed new diagnostic
criteria for Depression of Alzheimer’s disease, where fewer symptoms are required (three instead
of five) and symptoms of irritability and social withdrawal have been added.
A review of barriers to the diagnosis of depression in primary care by Docherty (1997)
identifies several other challenges in the detection of depression in primary care, including
patient-related, physician-related, and system-related factors. Patient-related factors that were
identified include lack of understanding of depression, variability in clinical presentation, and
reluctance to endorse depressive symptoms due to the negative stigma associated with mental
illness. Physician-related barriers to the detection of depression include lack of
knowledge/training in depression, reluctance to inquire about depression, and lack of confidence
in treating depression. Important system-related factors that interfere with depression detection
in primary care include reimbursement issues, lack of time available to patients, and
discontinuity in the physician/patient relationship.
Research has also demonstrated that cases of late-life depression that go undetected in
primary care settings have poorer prognosis than those that are detected (Licht-Strunk et al.,
2009). Though many studies have found that primary care physicians often fail to recognize
depression in older adults and several barriers have been identified, prior research has not
adequately examined the possibility that physicians may be more or less likely to detect
depression when certain symptom constellations are present.
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Presentation of late-life depression
Perhaps one of the most salient factors that may interfere with the clinician’s ability to
detect depression in older adults is the differential presentation of late-life depression. Research
has demonstrated that older adults are less likely than younger adults to endorse symptoms of
sadness or dysphoria. Gallo, Anthony, and Muthén (1994) examined data collected by the
Epidemiologic Catchment Area Program to compare age differences in depression symptom
endorsement. The researchers hypothesized that the emphasis placed on the dysphoria symptom
by the Diagnostic and Statistical Manual, 3rd ed. (DSM-III) may have led to an underestimation
in the prevalence of depression in older adults. The study consisted of 3,191 individuals from
thegreater Baltimore area and 3,469 from the Durham-Piedmont (NC) area. Gallo and
colleagues compared depressive symptomology between adults over age 65 and adults under age
65 within these samples. Symptoms of depression were assessed using the Major Depression
section of the Diagnostic Interview Schedule (DIS), which is based on the criteria for major
depression found in the DSM-III. A latent trait analysis revealed that adults aged 65 and older
were less likely to endorse dysphoria or anhedonia than younger adults, even after controlling for
gender, ethnicity, marital status, employment status, cognitive impairment, and overall level of
depression. Additionally, results showed that older adults were more likely to endorse appetite
disturbance and thoughts of death than younger adults.
Newmann, Engel, and Jensen (1991) had similar findings in a sample of women aged 50
and older. To examine age differences, the sample was divided into a younger cohort aged 52-65
(N=184) and an older cohort aged 66 and older (N=184). Symptoms of depression were
assessed using 16 items from the Symptom Checklist-90-Revised (SCL-90-R) Depression and
Additional Symptoms Scales. These items are also derived from the DSM-III criteria for Major
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Depression. Results provided evidence for two separate presentations of depression: one termed
“depressive syndrome,” in which the primary symptom is dysphoria, and another termed
“depletion syndrome,” in which the primary symptoms are appetite loss, anhedonia, thoughts of
dying, and hopelessness. Significantly higher levels of depletion syndrome were found in the
older cohort, compared to higher levels of depressive syndrome in the younger cohort. These
findings suggest that older adults may be more likely to endorse a presentation of depression that
differs from a more classic depressive syndrome, where dysphoric symptoms are the most
prominent.
These studies have demonstrated that the phenomenon of non-dysphoric depression is
more prevalent in older adults than in younger adults. Two different conceptualizations of
depression without dysphoria have been proposed. The first, “depletion syndrome” (previously
discussed) has the prominent symptoms of anhedonia, loss of appetite, hopelessness, and
thoughts of dying (Newmann et al., 1991). Another presentation, termed “depression without
sadness,” is characterized by feelings of hopelessness/helplessness, feelings of worthlessness,
and thoughts of death or suicide (Gallo, Rabins, Lyketsos, Tien, & Anthony, 1997). The
prominent symptoms of sadness and loss of interest are omitted in “depression without sadness.”
Because neither dysphoria nor anhedonia is endorsed, the DSM-IV criteria for major depression
cannot be met. However, treatment is still warranted, as individuals with this presentation are at
an increased risk for psychological distress, functional impairment, cognitive impairment, and
death (Gallo & Rabins, 1999).
Cognitive Impairment
One particular area of concern in the assessment of late life depression is cognitive
impairment. Specifically, the presentation of depression in individuals with cognitive
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impairment differs from a more classic conceptualization of depression where the chief symptom
is depressed mood. Many studies have noted the differential symptom profile of depressed
individuals with cognitive impairment. As mentioned previously, individuals with Alzheimer’s
disease are more likely to experience a sub-syndromal level of depression with chief symptoms
of irritability and social withdrawal (Olin et al., 2002). Likewise, stroke victims and individuals
with vascular dementia are more likely to display vegetative symptoms (i.e., weight loss, fatigue)
than symptoms of dysphoria or sadness (Pardiso et al., 2008; Park et al., 2007).
Another obstacle that may impede the valid assessment of depression in the context of
cognitive impairment is distinguishing between the two (Storandt & Vandenbos, 1994). This is
especially difficult because many symptoms overlap, and depression and cognitive impairment
can co-exist. Some overlapping symptoms include difficulty concentrating, impaired acquisition
of new information, and apathy (American Psychiatric Association, 2000). Dementia is often
accompanied by co-morbid psychiatric symptoms such as depression, anxiety, agitation, and
psychosis (Lopez et al., 2003). Reports of the occurrence of depressive symptoms in adults with
dementia vary widely, but most center between 30-50% (Steffens & Potter, 2007). There are
several possible explanations for this comorbidity. Depression may result as a reaction to a
dementia diagnosis (Jha, Tabet, & Orrell, 2001) or depression may be a prodromal symptom of
dementia (Schweitzer, Tuckwell, O’Brien, & Ames, 2002). Neuronal loss has also been
hypothesized to induce depression in older adults with dementia (Lyness, Zarrow, & Chui,
2003). The co-occurrence of depression and dementia is of particular clinical concern because it
is also associated with adverse health outcomes such as increased mortality (Mehta et al., 2003)
and functional impairment (Logsdon, McCurry, & Teri, 2008). In addition, caregivers of
individuals with dementia and co-morbid depression have been shown to have elevated levels of
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distress and depression compared to caregivers of demented individuals without depression
(Teri, McKenzie, & LaFazia, 2005).
Another complication is that most of the commonly used self-report measures for
depression ask respondents to recall experiences over a specified period of time (i.e., Beck
Depression Inventory, Center for Epidemiologic Studies- Depression Scale). This may be
problematic for individuals with cognitive impairment, as they have difficulties with memory.
Only one study to date has been conducted aimed at identifying the level of cognitive
impairment at which individuals are no longer accurate self-reporters of depression. Bédard et
al. (2003) examined responses on the Geriatric Depression Scale (GDS) and found that
participants with Mini-Mental State Exam (MMSE) scores of 18 or below (suggestive of
moderate-severe dementia) answered significantly fewer items, were more likely to endorse
questions framed positively, and demonstrated less consistency in responses between two time
periods. However, no studies have replicated these findings or examined other self-report
measures for depression.
Possible Moderators of Clinician Detection of Late Life Depression
There are a number of factors that complicate clinicians’ abilities to detect late-life
depression. Several studies have shown that clinicians may be more likely to detect depression
when symptoms are more severe. Coyne, Schwenk, and Fechner-Banks (1995) conducted a
study to identify factors that facilitated or interfered with the detection of depression in primary
care. They examined physician performance in diagnosing depression in 1580 patients screened
for major depression using the Center for Epidemiologic Studies- Depression Scale (CES-D) and
the Structured Clinical Interview for DSM-III-R (SCID). Coyne and colleagues found that those
who were undetected had lower CES-D scores and higher levels of functioning compared to
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patients who were detected by their physician. Additionally, detected patients rated themselves
as being more depressed and as having less energy than undetected participants. These results
are particularly relevant, since older adults are more likely than other age groups to experience
subsyndromal levels of depression (Fiske, Wetherell, & Gatz, 2009).
The differential presentation of late-life depression may also affect the likelihood of
clinician detection. Older adults are more likely than younger adults to present with nondysphoric depression (Gallo et al., 1994; Newmann et al., 1991). In addition, as previously
discussed, older adults with cognitive impairment often experience a subsyndromal level of
depression with chief symptoms of anhedonia and irritability (Olin et al., 2002). Thus, it is
possible that clinicians may be under-diagnosing depression in older adults if they are
differentially biased towards diagnosing depression when the symptom of sadness or dysphoria
is endorsed.
There are many possible explanations for why clinicians might privilege dysphoria when
diagnosing depression. In particular, the DSM-IV criteria for major depression emphasize
dysphoria (American Psychiatric Association, 2000), which is less frequently endorsed by older
adults (Gallo et al., 1994; Newmann, et al., 1991; Fiske &O’Riley, 2008). Clinicians may also
have difficulty in diagnosing depression because current diagnostic criteria for major depression
require a judgment that presenting symptoms cannot be attributed to the effects of a medication,
a medical condition, or a recent bereavement (American Psychiatric Association, 2000), all of
which increase with age. As medical conditions and bereavement increase, it may become more
difficult for clinicians to judge what symptoms are attributable to depression.
A number of recommendations have been proposed to address screening for depression in
primary care; though, none takes into account the differential symptom presentation of
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depression in late life. The U.S. Preventive Services Task Force, a panel of experts in primary
care and prevention that develops recommendations for clinical preventive services, advocates
for screening for depression in primary care settings, even if the screening consists of only two
questions regarding depressed mood and anhedonia in the past 2 weeks (U.S. Preventive
Services Task Force, 2009). This screening may not be sensitive enough for older adults, since
symptoms may be mistakenly attributed to physical illness or bereavement, older adults have
higher incidence of milder depression, and depression in late-life often presents without
sadness/depressed mood. Primary care physicians often note that the atypical presentation of
late-life depression is a barrier to the assessment and treatment of depression in older adults
(Gallo, Ryan, & Ford, 1999).
Little research has been conducted to determine whether clinicians privilege certain
symptoms when assessing depression. Klinkman, Coyne, Gallo, & Schwenk (1998) conducted a
study with 50 primary care physicians and 1580 patients in southeastern Michigan to examine
clinical characteristics of patients with or without depression who were correctly or incorrectly
identified. A weighted sample of 372 patients was administered the Structured Clinical
Interview for DSM-III-R (SCID) within a two-week window following a visit to their primary
care physician. Immediately following the patient’s visit to his/her physician, the physician was
asked to rate the level of depression, general health, and stress of the patient. The physician was
also asked to report (yes or no) whether the patient had a clinically significant level of depressive
symptoms. The weighted sample of patients was then categorized into true positives, false
positives, false negatives, and true negatives based on scores on the SCID and identification or
non-identification by primary care physician. Results showed that depressed patients were more
likely to be detected by their physician if they had previously received treatment for depression,
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rated themselves as having higher levels of depression, and scored higher on the CES-D. There
were no differences in the clinical characteristics of the false negative and false positive group.
Results suggested that physicians discriminated between these two groups solely based on their
knowledge of the patient’s psychiatric history.
With regard to somatic symptoms such as fatigue and sleep difficulty, Klinkman (2003)
notes that they have little predictive value in primary care settings. He cites that the baseline
rates of fatigue, sleep difficulty, and appetite disturbance in non-depressed primary care patients
is about 20%. However, there is evidence that not attending to these somatic symptoms may
impair the detection of depression in primary care. One recent study examined the effect of
patients’ symptom presentation on the recognition of depression by physicians in a sample with
191 primary care providers and 1910 patients in Italy (Menchetti, Murri, Bertakis, Bortolotti, &
Berardi, 2009). The researchers found that odds ratios for non-recognition were significantly
higher for patients presenting with physical complaints (2.3; 95% CI=1.1-5.3) and pain (4.1;
95% CI=1.6-9.9) compared to patients with chief psychological complaints (Menchetti et al.,
2009). These findings are particularly relevant to older adults, as they are less likely than
younger adults to endorse dyspohoria or sadness, and more likely to endorse the somatic
complaints of sleep disturbance and appetite loss (Newmann et al., 1991; Gallo et al., 1994). It
should be noted that many medical illnesses are known to cause depression (Alexopoulos et al.,
2001) and many clinicians note the importance of considering somatic symptoms, but also
encourage caution in interpretation (Edelstein, Drozdick, & Ciliberti, 2010).
Research has demonstrated that physicians are less likely to detect depression in
individuals with chief somatic complaints and more likely to detect depression in individuals
with greater symptom severity and with prior clinical history. These studies demonstrate that
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symptom presentation does make a difference in whether a clinician is more or less likely to
detect depression. However, more research is needed to determine what symptoms (i.e.,
depressed mood) may have greater predictive value in the diagnosis of depression.
Statement of the problem
Depression in late life is associated with many negative health outcomes, including
increased risk of suicide, decreased cognitive functioning, increased functional and social
impairment, and increased mortality. Many evidence-based treatments for late-life depression
exist, even in the context of cognitive impairment and dementia. Though many treatments exist,
older adults are less likely than younger adults to be diagnosed with depression and
psychotherapy is underutilized in older adults compared to pharmacological treatments (Fiske et
al., 2009). Prior research has not adequately examined potential clinician-related factors that
may interfere with the detection of depression in late life.
The differential presentation of depression in late life and the presence of cognitive
impairment have been identified as potential barriers to the assessment and detection of
depression in older adults. Prior research has demonstrated that older adults are less likely than
younger adults to endorse symptoms of dysphoria and sadness, and more likely to endorse
appetite disturbance, anhedonia, and thoughts of death. Research has also demonstrated that
clinicians are more likely to detect depression when it is more severe and when the patient has
received prior mental health services. Additionally, several studies have demonstrated that
clinicians often fail to recognize depression when the chief symptoms are somatic in nature.
Though, prior research has not established whether clinicians may be more likely to diagnose
depression based on the particular symptoms that are endorsed (i.e. depressed mood). Research
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on this topic may help to explain low rates of clinician detection of depression in late-life and
may have implications for the assessment of depression in older adults.
Specific Aim. Characterize the relation between depressive symptom endorsement and
detection of depression in older adults.
Based on prior research, it is hypothesized that greater depressive symptom endorsement
will be associated with clinician detection of late-life depression (Simon &VonKorff, 1995).
Furthermore, because a number of factors have been identified that may cause clinicians to
privilege sadness or depressed mood, it is hypothesized that clinicians will be more likely to
detect depression in older adults if the patient endorses that particular symptom. In addition,
because older adults with cognitive impairment are also less likely to endorse dysphoria and
because of the difficulty in distinguishing between cognitive impairment and depression,
presence of cognitive impairment is also hypothesized to be a factor that may interfere with the
clinician detection of depression in late life.
Hypothesis 1: Greater depressive symptom endorsement will increase the likelihood that
clinicians will diagnose late-life depression.
Hypothesis 2: Endorsement of depressed affect will moderate the relation between overall level
of depressive symptoms and clinician detection of depression. Overall depressive symptoms will
be more strongly related to the diagnosis of depression when symptoms of depressed affect are
endorsed.
Hypothesis 3: Presence of cognitive impairment will moderate the relation between overall level
of depressive symptoms and the diagnosis of depression in older adults. Specifically, overall
depressive symptoms will be more strongly related to the diagnosis of depression in the absence
of cognitive impairment.
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Method
Participants
Participants for the current study were obtained from the Swedish Twin Registry (STR).
The registry was originally established in the early 1960’s to study the effects of smoking on
health (Cederlöf, 1966). The STR is now the largest well-characterized twin registry in the
world, and, over the years, many research projects have been initiated using the registry. The
current study utilized data collected from one such project known as the Swedish Adoption/Twin
Study of Aging (SATSA; Pedersen, Plomin, Nesselroade, & McClearn, 1992). SATSA data
collection began with a comprehensive questionnaire in 1984 and subsequent questionnaires
were administered in 1987 (Q2), 1990 (Q3), 1993 (Q4), and 2004 (Q5). Additionally, a subset of
the twins was recruited to participate in a more comprehensive battery (including an evaluation
of cognitive abilities) via in-person testing (IPT) at five time periods between 1985 and 2004.
Only data collected between 1986 and 1994 were used for the current study, since the Center for
Epidemiologic Studies- Depression Scale (CES-D) was not included in 1984 and medical
diagnoses have not been coded through 2004.
A total of 3,838 individuals were originally contacted to participate in the SATSA
project. Not all participants responded to the questionnaires at each time point, with 1,637 at Q2,
1,406 at Q3, and 1,450 at Q4. Considering the sample at the time of Q2, the response rates for
those alive at Q3 and Q4 were 86% and 90% respectively (Wetherell, Gatz, & Pedersen, 2001).
A smaller subset of participants was included in the in-person testing with 645 individuals
participating at IPT1 (1986-1988), 595 at IPT2 (1989-1991), and 569 at IPT3 (1992-1994).
Medical records have been coded for a smaller subset of 476 individuals who participated in the
in-person testing. Three hundred forty-four of these individuals were aged 50 or older at the
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time of Q2 in 1987. Because the current study focuses on the detection of late-life depression,
only participants aged 50 and older at the time of this surveywere included. Thus, the final
sample size for the present study was 344. Of these 344, there were 138 men (40.1%) and 206
women (59.9%). The average age of participants at the time of Q2 was 61.2 (SD = 7.4).
The SATSA project was chosen for the present study because it includes a large, wellcharacterized, population-based sample with measures of depressive symptoms and cognitive
functioning at several time points, in addition to coded primary care diagnoses.
Measures
Depressive Symptoms. Depressive symptoms were assessed by item endorsement on the
Center for Epidemiologic Studies- Depression Scale (CES-D). The CES-D is a twenty-item
measure that asks individuals to respond to items on a 4-pt Likert-type scale based on their
symptomsin the past week. The CES-D contains items that assess depressed affect, well-being
(or absence thereof), somatic complaints, psychomotor retardation, interpersonal difficulties, and
other symptoms of depression. The CES-D has demonstrated good internal consistency, testretest reliability, and validity (Radloff, 1977), and has been shown to have measurement
equivalence across the lifespan (Gatz, Johansson, Pederson, Berg, & Reynolds, 1993). For the
SATSA project, items were translated into Swedish and were backtranslated by another
individual to ensure that the original meanings were retained. Factor analyses have shown
evidence for four factors; depressed affect, psychomotor retardation, absence of well-being, and
interpersonal difficulties (Gatz et al., 1993). This is a similar factor structure to that found in
U.S. samples, suggesting that the measure functions in a similar way across these cultures. A
cut-off score of 16 on the CES-D is the most commonly validated criterion (Craig & Van Natta,
1973; Radloff, 1977). Furthermore, the majority of studies that utilize the CES-D have used 16
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as the cut-off score for clinically significant depressive symptoms, including those with older
adult samples (e.g., Gatz & Hurwicz, 1990). There is some debate with regard to whether the
cutoff should be raised for older adults due to items relating to physical illness and bereavement
(Beekman, Deeg, Limbeek, Braam, de Vries, & van Tilberg, 1997). For example, one study
found the CES-D to have high sensitivity (96.2%), but poor specificity (23.8%) using a cutoff of
16 in one study with Dutch older adults (ages 55-85) with or without MDD (Haringsma, Engels,
Beekman, & Spinhoven, 2004). However, the CES-D has been shown to have only minimal
overlap with physical illness (Berkman et al., 1989).
Descriptive statistics and Pearson’s correlations for the CES-D at each of the 6 time
points (Q2, Q3, Q4, IPT1, IPT2, and IPT3) are presented in Table 1. Correlations between the
CES-D at various time points ranged from .57-.74 (all p’s<.001). These significant correlations
corroborate prior findings that CES-D scores are relatively stable over time (Fiske, Gatz, &
Pedersen, 2003). This pattern of stability also appeared to be true for those with higher CES-D
scores. For example, for those above the clinical cutoff of 16 at the time of Q2, CES-D scores at
Q2 were significantly related to CES-D scores at all five other time points (r’s=.28-.69, all
p’s<.05). In the current study, the participant’s highest CES-D at any time point was used for
each analysis. The mean of participants’ highest CES-D scores was 15.4 (SD = 9.1). The “high
CES-D” variable also met the underlying assumption of normality, with acceptable skew (.81)
and kurtosis (.26).
Depressed Affect. Endorsement of depressed affect (sadness/dysphoria) was determined
using two items from the CES-D. These two items were selected based on face validity and
included “I felt depressed” and “I felt sad.” Other items on the “depressed affect” subscale were
not included because they do not require the participant to endorse depressed mood. These items
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included “I thought my life had been a failure,” “I felt afraid,” “I felt lonely,” and “I cried.” As
with the full scale CES-D, the participant’s highest item endorsement of any time point was used
for the current study. Descriptive statistics for these variables are presented in Table 2.
Cognitive Functioning. Cognitive abilities were determined using data from the
cognitive battery included in the in-person testing (IPT) portion of SATSA. Subjects were
administered tests of fluid intelligence, crystallized intelligence, and specific cognitive abilities.
In particular, an overall measure of “general cognitive ability” was compiled using data from all
the different subtests including block design, synonyms, information, figure logic, digit span,
Thurstone’s picture memory, names and faces (immediate and delayed), card rotations, digit
symbols, analogies, and figure identification (see Table 3 for more detail). Specifically, this
measure of “general cognitive ability” was created using the 1st principal component of all the
measures described residualized for gender. In the present study, the measure of cognitive
ability was available for 317 of the 344 participants for at least one of the three IPTs. The lowest
cognitive score at these three time points was used in the present analyses (M = -0.03, SD = 0.93,
skew = 0.00, kurtosis = 0.15). Lower scores on this overall measure are indicative of poorer
cognitive functioning.
Clinician Detection of Depression. Clinician detection of depression was assessed using
medical records coded by a project physician according to the ICD-10 diagnostic rubric.
Relevant diagnoses included ICD F30-F34 (Depression) and ICD F32.0 (Depression, mild). The
coded diagnoses for depression also included the year in which the diagnosis was given.
Diagnoses were considered in the analyses if they were given between 1986 and 1994. In the
current study, 14 out 344 participants (4.1%) were diagnosed with depression during 1986-1994.
Seven participants were diagnosed with major depressive disorder and 7 participants were
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diagnosed with mild depression. Of those with a depression diagnosis, 4 were men (28.6%) and
10 were women (71.6%).
Analyses
For the present study, a series of simple logistic regressions were conducted. All of the
independent variables (i.e., overall depressive symptoms, endorsement of depressed affect, and
level of cognitive functioning) were tested as continuous variables. The rationale for this
strategy was two-fold. (1) The use of continuous variables allowed for greater power than
dichotomous variables. This was especially important in the present study, since the outcome
variable (i.e., diagnosis of depression) was a relatively rare event, occurring in only 4.1% of
participants. (2) By examining the variables as continuous measures, variability was preserved
that would otherwise have been lost through the use of a dichotomy (i.e., not above clinical
cutoff on the CES-D vs. above clinical cutoff on the CES-D). For example, a person with a
CES-D score of 16 seemed qualitatively different from a person with a CES-D score of 40, even
though both were above the clinical cutoff. Likewise, a person who rated the “I felt depressed”
item as a 3 (“most or all of the time”) seemed more likely to endorse depressed affect to their
physician compared to a person who rated the same item as a 1 (“some or little of the time”).
Logistic regression makes no assumptions about the distribution of the independent
variables; however, preliminary analyses assessed normality. All of the test variables had skew
and kurtosis values between -1 and 1, suggesting that none deviated significantly from normality.
In all of the regression models, continuous variables were centered to avoid problems associated
with multicolinearity. Furthermore, though the current study utilized a twin sample, it did not
make use of the genetically informative nature of the dataset. Thus, corrections were made to
confidence intervals using robust standard errors to adjust for non-independence of observations.
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In order to make these corrections, a SAS macro was employed (SAS Institute, 2003).
Specifically, this macro assessed the correlation between twin pairs and increased the variance
estimates in proportion with the correlation. This expanded the confidence intervals and allowed
for a more conservative estimate of the effect.
Results
Hypothesis 1: Greater level of depressive symptoms will increase the likelihood that
clinicians will diagnose late-life depression.
For this hypothesis, the participant’s highest CES-D score (at any of the time points
included) was used as an indicator oflevel of depressive symptoms. A logistic regression
analysis was conducted with highest score on the CES-D as the independent variable and
diagnosis of depression as the dependent variable. After controlling for sex and age, CES-D
scores were significantly related to clinician diagnosis, Wald Test = 12.61, p < .001 (OR = 1.10,
95% CI: 1.03-1.17). A one unit increase in scores on the CES-D increased the likelihood of
receiving a diagnosis of depression by 10%.
A follow-up analysis assessed the agreement between presence of clinically significant
depressive symptoms (score ≥ 16 on the CES-D at any time point) and clinician diagnosis of
depression using a Kappa analysis. Overall, there appeared to be poor agreement between
clinically significant scores on the CES-D and clinician diagnosis of depression (kappa = .04).
One hundred forty-five participants (42.2%) had a CES-D score greater than 16 at some point,
compared to 14 (4.1%) who received a depression diagnosis from a clinician.
Hypothesis 2: Endorsement of depressed affect will moderate the relation between
overall level of depressive symptoms and clinician detection of depression. Greater level of
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depressive symptoms will be more strongly related to the diagnosis of depression when
depressed affect is endorsed.
To test hypothesis 2, a logistic regression analysis was run with level of depressive
symptoms and endorsement of depressed affect as predictors of clinician diagnosis of depression.
An interaction term (overall level of depressive symptoms X endorsement of depressed affect)
was then added to the model to determine whether endorsement of depressed affect moderated
the relation between overall level of depressive symptoms and clinician diagnosis. Participants’
highest CES-D score (at any of the time points included) was used as an indicator of level of
depressive symptoms. Likewise, participants’ highest rating of depressed affect items on the
CES-D (“I felt depressed” plus “I felt sad”) was used as an indicator of endorsement of
depressed affect. When both variables were present in the regression model, only the
endorsement of depressed affect was significantly related to the clinician diagnosis of
depression, Wald Test = 4.07, p<.05 (OR = 2.05, 95% CI: 1.42-4.10). Overall level of
depressive symptoms no longer predicted clinician diagnosis, Wald Test = 0.00, p=.96 (OR =
1.00, 95% CI: 0.91-1.11). The interaction between overall level of depressive symptoms and
endorsement of depressed affect approached, but did not reach, significance, Wald Test = 3.27, p
= .07 (OR = 0.97, 95% CI: 0.94-1.03).
Logistic regression analyses were then run separately for the two items related to
depressed affect, to examine whether the two items may perform differently. First, participants’
highest individual rating of the “sad” item was used instead of the combined depressed affect
items. Unlike depressed affect, the endorsement of sadness was not related to the clinician
diagnosis of depression independently of overall level of depressive symptoms, Wald Test =
0.18, p = .67 (OR = 1.26, 95% CI: 0.44-3.62). In addition, the endorsement of sadness did not
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moderate the relation between overall level of depressive symptoms and clinician diagnosis,
Wald Test = 0.04, p = .84 (OR = 1.01, 95% CI: 0.94-1.07).
Next, the participant’s highest rating of the “depressed” item was examined. With both
endorsement of the depressed item and overall level of depressive symptoms in the regression
equation, only the endorsement of the depressed item was related to the clinician diagnosis of
depression, Wald Test = 7.39, p < .01 (OR = 2.75, 95% CI: 1.33-5.69). Overall level of
depressive symptoms was no longer independently related to clinician diagnosis after accounting
for endorsement of the depressed item, Wald Test = 0.54, p = .46 (OR = 1.03, 95% CI: 0.961.10). The interaction between overall level of depressive symptoms and endorsement of the
depressed item was also significant, Wald Test = 5.37, p < .05 (OR = 1.07, 95% CI: 1.02-1.12),
indicating that the endorsement of the depressed item moderated the relation between overall
level of depressive symptoms and the clinician diagnosis of depression. To further characterize
this relation, separate regression analyses were run examining the relation between overall level
of depressive symptoms in those with higher endorsement of the depressed item versus those
with lower endorsement of depression utilizing a mean split. As anticipated, the relation
between overall level of depressive symptoms and clinician diagnosis of depression was stronger
in those with higher endorsement on the depressed item, Wald Test = 8.85, p < .01 (OR = 1.11,
95% CI: 1.04-1.19). The relation between overall symptoms and depression diagnosis was not
significant in those with lower endorsement on the depressed item, Wald Test = 0.24, p = .62
(OR = 1.07, 95% CI: 0.83-1.37). None of the relations described was altered after including sex
and age as covariates.
Hypothesis 3: Cognitive functioning will moderate the relation between overall level
of depression and diagnosis of depression in older adults. Specifically, clinically significant
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depressive symptoms will be more strongly related to the diagnosis of depression in the
absence of cognitive impairment.
In order to test hypothesis 3, a logistic regression analysis was run with overall level of
depressive symptoms and cognitive functioning as predictors of the clinician diagnosis of
depression. An interaction term (overall level of depressive symptoms X cognitive functioning)
was then added to the model to determine whether cognitive functioning moderated the relation
between overall level of depressive symptoms and clinician diagnosis. Because the
presence/absence of cognitive impairment was the target variable, participants’ lowest “general
cognitive ability” score was used as an indicator of cognitive functioning. Cognitive functioning
was not related to depression diagnosis over and above overall symptoms of depression, Wald
Test = 0.21, p = .65 (OR = 1.17, 95% CI: 0.59-2.23). In addition, the inclusion of the interaction
between overall level of depressive symptoms and cognitive functioning did not add anything to
the model, Wald Test = 0.68, p = .41 (OR = 0.97, 95% CI: 0.89-1.05). A post-hoc descriptive
analysis revealed that mean cognitive functioning scores were slightly lower for individuals with
significant self-reported depressive symptoms (i.e., CES-D ≥ 16), but no clinician diagnosis of
depression (n = 128, M = -0.30, SD = 0.88) compared to those with significant self-reported
diagnosis and a clinician diagnosis of depression (n = 7, M = -0.25, SD = 0.60). However, this
difference was not statistically significant.
Discussion
Findings from the present study affirm that symptom presentation plays an important role
in the clinician assessment of late-life depression. Results suggest that overall level of
depressive symptoms is related to receiving a clinician diagnosis of depression. In addition, this
relationship is moderated by the endorsement of a single item on the Center for Epidemiologic
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Studies- Depression Scale (i.e., “I felt depressed”). When this particular item is rated highly, the
relation between overall level of depressive symptoms and clinician diagnosis of depression is
stronger compared to lower ratings of the same item. However, other items on the CES-D
related to depressed affect (i.e., “I felt sad”) do not appear to have the same moderating affect.
These findings suggest that clinicians are particularly focused on the endorsement of
“depression” versus the endorsement of depressed affect more generally in older adults. This
relationship is especially pertinent to older adults, given that this population is less likely to
endorse depressed affect and less likely to use the term “depression” compared with younger
adults (Gallo & Rabbins, 1999). The notion that clinicians are biased toward detecting
depression only in the context of endorsement of the “depression” item may lead to false
negatives in the diagnosis of depression in late life.
Findings from the current study also corroborate prior studies that show a disparity
between level of depressive symptoms in late-life and prevalence of diagnoses. Forty-two
percent of older adults in the present sample had clinically relevant levels of depressive
symptoms on the CES-D, but only 4% had been diagnosed with depression by a clinician. A
number of factors may play a role in this relation. For example, it has been hypothesized that
older adults’ scores on the CES-D may be inflated due to higher rates of physical illness and
bereavement (Beekman et al., 1997). However, it is also possible that ageism may be
responsible for the misattribution of somatic symptoms to aging as opposed to symptoms of
depression.
Unlike the endorsement of the depression item, the present study shows that level of
cognitive functioning does not moderate the relation between overall level of depressive
symptoms and clinician diagnosis of depression. There are a number of reasons that may help
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explain this non-finding. All of the participants in the present sample were able to complete selfreported measures of depression, suggesting that more severe levels of cognitive impairment
may not have been represented (i.e., moderate-severe dementia of the Alzheimer’s type). It is
also possible that there has been an increase in the awareness of the high prevalence of
depression in the context of dementia. For example, those suspected of dementia may have
undergone a more thorough medical or neuropsychological evaluation, which often includes
formal screening for depression.
Though the prevalence of major depression declines with age, endorsement of depressive
symptomatology increases in older adults. In addition, older adults suffering from depression are
at a higher risk than non-depressed older adults for functional impairment, cognitive impairment,
social impairment, death, and suicide. These risk factors make the accurate and valid assessment
of depression in late life a critical public health issue. This study examined the idea that
clinicians may be differentially biased in diagnosing depression if sadness/dysphoria is endorsed.
This study also examined whether presence of cognitive impairment may be a barrier to the
diagnosis of depression in late life. These are especially pertinent to older adults, as older adults
are more likely than younger adults to have either cognitive impairment or non-dysphoric
depression. As identified in the study, the privileged symptom of endorsement of “depression”
may result in the under-diagnosis of depression in late life.
There are a few limitations in the present study. For one, the study operationally defines
clinician detection of depression as assigning a diagnosis of major or minor depression. It is
possible that clinicians may detect depression without giving a diagnosis (Rost, Smith,
Matthews, & Guise, 1994). This phenomenon could inflate the findings of the current project.
Though, if a diagnosis for a patient is not rendered, it is unlikely that they are receiving treatment

Diagnosis of Depression in Late Life 24
for depression. Another potential limitation is that the present study operationally defines
endorsement of depressed affect by item endorsement on the CES-D. However, we do not know
what information the participants disclose to their physicians regarding depressive symptom
endorsement. Nevertheless, we found a significant relation between self-reported depressive
symptoms and clinician diagnosis of depression in the present study. Another potential
limitation is that the timing of CES-D administration and physician office visits was not
coordinated. Though, it should be noted that CES-D scores are quite stable over time (Fiske et
al., 2003). These limitations notwithstanding, the present study was the first to examine clinician
bias toward diagnosing depression when depressed mood is endorsed.
Regarding the clinical implications of the present study, results suggest that clinicians
may benefit from improved awareness of the unique presentation of depression in late life.
Clinicians who are differentially biased in diagnosing depression in the presence of endorsement
of feeling “depressed” are likely to miss many depressed older adults who do not use this
language or who present with predominant psychomotor symptoms of depression. Thus,
programs that educate clinicians about the unique aspects of late-life depression may aid in
correcting this bias.
It should be noted that older adults benefit from many of the same psychotherapy
interventions as younger adults, including individual, group, and family therapies (Karel &
Hinrichsen, 2000). A number of evidence-based treatments exist for depression in late life,
including cognitive behavioral therapies (e.g., Coon, Rider, Gallagher-Thompson, & Thompson,
1999), interpersonal psychotherapies (e.g., Hinrichsen, 1999), and some pharmacological
treatments (see Beyer, 2007). A number of psychosocial treatments for depression have also
been shown to be effective in older adults with dementia (see Teri, McKenzie, & LaFazia, 2005).
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However, it has been noted that psychological interventions for depression are underutilized in
older adults compared to pharmacological treatments for depression (Fiske, Wetherell, & Gatz,
2009). With improved detection of depression in late life, these therapies may be available to
more individuals who could really benefit from treatment for depression.
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Table 1. Means, standard deviations, and Pearson’s correlations for Center for Epidemiologic
Studies Depression Scale at each time point.
Time Point

n

Mean

SD

Q3

Q4

IPT1

IPT2

IPT3

Q2

314

9.9

7.9

.67

.59

.74

.61

.61

Q3

317

10.6

7.8

-

.63

.57

.67

.64

Q4

323

11.5

8.9

-

-

.62

.63

.64

IPT1

111

11.1

8.5

-

-

-

.57

.60

IPT2

274

9.7

8.1

-

-

-

-

.64

IPT3

260

9.4

6.7

-

-

-

-

-

Note: Q= Questionnaire, IPT= In-Person Testing. All correlations significant at the p<.001 level.
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Table 2. Descriptive statistics for participant’s highest Center for Epidemiologic StudiesDepression scale (CES-D), depressed affect total, and individual item totals at any time point.
Scale/Item

n

Mean

SD

Skewness

Kurtosis

Total CES-D

344

15.44

9.13

0.81

0.26

Depressed Affect Total

344

1.71

1.47

0.62

-0.46

‘Depressed’ Item

344

0.82

0.90

0.90

-0.06

‘Sad’ Item

344

1.00

0.81

0.46

-0.34
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Table 3. Measures of Cognitive Ability from SATSAa
Test Name
Digit Span Forward and
Backward
Thurstone’s Picture
Memory
Names and Faces
(Immediate & Delayed)
Information
Synonyms
Analogies
Figure Logic
Kohs Block Design
Card Rotations
Digit Symbol
Figure Identification

Domain/Specific Cognitive
Ability
Memory

Resource
WAIS (Swedish version)

Memory

DS Battery

Memory

Colorado Adoption Project

Crystallized/Verbal
Crystallized/Verbal
Fluid and crystallized/Verbal,
reasoning
Fluid/Spatial, reasoning
Fluid/Spatial
Spatial
Perceptual speed
Perceptual speed

WAIS (Swedish version)
DS Battery
WIT-III
DS Battery
DS Battery
Educational Testing Service
WAIS
DS Battery

Note: a Table adapted from Pedersen, Plomin, Nesselroade, & McClearn, 1992; WAIS =
Wechsler Adult Intelligence Scale; DS Battery = Dureman-Salde Battery.
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